BMC Ophthalmology · 2019 · 12 citations · 11 references
MedicineOphthalmologySurgeryMyopia ManagementOcular DiseaseOphthalmic SurgeryMacular DegenerationMacular DiseaseMacular DisordersRetinal DetachmentRetinal SurgeryVitreoretinal SurgeryAnti-vegf Ocular TherapyIntravitreal Anti-vascular Endothelial Growth Factor TherapyMacular NeovascularizationMyopic Choroidal NeovascularizationNeovascularizationSerous Retinal DetachmentVascular Endothelial Growth FactorVitrectomy For Macular Disease
BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months' follow-up. CONCLUSION: MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation.
11
Full thickness macular hole case after intravitreal aflibercept treatment
Yuji Oshima, Rajendra S. Apte, Shintaro Nakao et al. · BMC Ophthalmology · 2015 · 37 citations · Full text
Medicine, Ophthalmology, Surgery +16
Elad Moisseiev, Michaela Goldstein, Anat Loewenstein et al. · Case Reports in Ophthalmology · 2010 · 30 citations · Full text